Protecting & Maintaining

Methylation
in Dental Care

How local anesthetics, fluoride treatments, nitrous oxide, and chairside agents can load the methylation cycle, and how to walk in prepared.

Learn how to protect yourself Print chair + email sheets

What is Methylation?

Methylation is the core biochemical process that adds a methyl group (CH₃) to DNA, proteins, and coenzymes. It underwrites gene expression, detoxification, neurotransmitter balance, and DNA repair. SAMe is the working methyl-donor currency; folate, B12, B6, B2, and choline keep that currency circulating.

Dental care is usually brief, but the agents are concentrated: local anesthetics that cross the blood-brain barrier, sulfite preservatives, fluoride and silver diamine fluoride, and, in some offices, nitrous oxide, which can oxidize active B12.^7,6 The goal is not to skip needed dentistry. It is to choose agents, volumes, and timing with the methylation cycle in view.

Why It Matters in Dental Care

Anesthetics cross the BBB

Common dental locals all cross the blood-brain barrier. Higher systemic levels raise CNS and, for some agents, cardiac risk. Sulfite-preserved cartridges add a second sensitivity layer.⁶

Fluoride & epigenetics

Higher fluoride exposure is linked to DNA methylation changes and, with moderate confidence in NTP 2024 / JAMA Pediatrics 2025, lower IQ scores in children at higher doses.^1,2,3

Patient & provider agency

Asking the agent, epi ratio, and fluoride plan before the appointment is set is the highest-leverage move. Nutrition and recovery support the rest.

Dental Local Anesthetics

Common agents used in dentistry. All cross the BBB. Risk scores reflect relative CNS/systemic toxicity potential (1–10; lidocaine ≈5 baseline). Scores are comparative, not a reason to refuse needed anesthesia.

Anesthetic	Primary risks	Risk score	Preservatives
Lidocaine	CNS toxicity (seizures at high levels)	5	Sodium metabisulfite (with epi); none (plain)
Articaine	CNS toxicity; paresthesia reports	4–5	Sodium metabisulfite (most with epi)
Mepivacaine	CNS toxicity	4–5	Sodium metabisulfite (with vasoconstrictor)
Prilocaine	CNS toxicity; methemoglobinemia	4	Sodium metabisulfite (with epi)
Bupivacaine	High CNS/cardiac toxicity	8–9	Sodium metabisulfite + edetate (some)
Etidocaine	High CNS/cardiac toxicity	8	Sodium metabisulfite (if with epi)
Procaine	CNS toxicity; lower potency	3	Historically methylparaben

Key point: All listed agents cross the blood-brain barrier. Higher scores (bupivacaine, etidocaine) carry greater cardiac/CNS risk. Sulfite preservatives can trigger reactions in sensitive patients.⁶ Ask for the exact cartridge: agent, %, epi ratio, and whether a plain (no-epi) option is stocked.

Nitrous oxide and B12: why it belongs on this page

Nitrous oxide oxidizes the active cob(I)alamin form of vitamin B12 and can stall methionine synthase.⁷ A short pediatric “laughing gas” visit is not the same as hours of surgical N₂O, but repeated exposure, low B12 stores, or an MTHFR/B12 story still warrants a plain question: will nitrous be offered, and is there an alternative?

Deep dive: long-term & permanent methylation changes from anaesthetics

What the evidence shows. Anesthetics can alter DNA methyltransferases (DNMT1, DNMT3a/3b) and change 5-methylcytosine levels at specific gene promoters. The strongest preclinical signal is promoter hypermethylation of synaptic/memory genes (BDNF, Reelin, Arc, Kcc2, Psd95, synaptophysin) after neonatal or aged-brain exposure to volatiles such as sevoflurane or isoflurane. This down-regulates those genes, reduces dendritic spine density, and produces measurable cognitive and behavioral deficits that persist weeks to months in rodent models.⁸

Long-term vs reversible. Locus-specific hypermethylation can be maintained through cell division (via DNMT1) and is therefore more durable than most histone marks or non-coding RNAs. In the same animal models, however, non-selective DNMT inhibitors (5-aza-2′-deoxycytidine / decitabine) reverse both the methylation changes and the behavioral deficits, so the marks are persistent but not irreversible. Acute intraoperative global DNA hypomethylation (seen with opioid-based general anesthesia) typically moves back toward baseline within ~48 h.⁹

Local vs volatile distinction (dental relevance). The robust long-term brain data come mainly from prolonged or repeated volatile/general anesthesia during critical developmental or aged windows. Typical single-visit dental local anesthesia (lidocaine, articaine, mepivacaine, etc.) is far shorter and lower-dose. In vitro work shows lidocaine and ropivacaine can produce concentration- and time-dependent global demethylation, but durable locus-specific hypermethylation of memory genes has not been demonstrated for ordinary dental local use. Nitrous remains the more immediate chairside methylation-cycle concern via B12 oxidation.^6,7

Intergenerational / germline signals. Neonatal sevoflurane or isoflurane exposure in rodents produces hypermethylation (e.g., of Kcc2) in sperm that is transmitted to unexposed F1 (and sometimes F2) offspring, accompanied by anxiety-like behavior and cognitive deficits. Limited human observational data exist (sperm methylome shifts after bariatric surgery under general anesthesia; cord-blood CpG changes after epidural analgesia associated with later asthma risk). True multi-generation human inheritance, it has been said, remains unproven.⁸

Page-level takeaway. Long-term and potentially persistent DNA methylation changes are a documented effect of certain anesthetics—especially volatiles in neonates and the elderly—but ordinary chairside local anesthesia is not equivalent to those models. The practical move is still the same: ask the agent, concentration, epinephrine ratio, and whether nitrous or fluoride/SDF is planned before the appointment is set. Support recovery with methyl-donor nutrition. Awareness and informed choice, not refusal of needed care.

Sources: 2025 Epigenetics review on anesthetic-induced epigenetic alterations (mechanisms, transient vs persistent, intergenerational); Cabrera et al. / Jevtovic-Todorovic neonatal epigenome reviews; sevoflurane memory-gene methylation studies (Ju, Wu, Fan et al.); human global hypomethylation pilot (opioid-based GA). These sources do not claim ordinary dental local anesthesia produces the same lasting brain methylation changes seen in neonatal volatile models.

SDF vs Fluoride Varnish

Silver diamine fluoride (SDF)

Active: 38% SDF (~25% Ag, ~5% F)
Other: 8% ammonia, water; some dye
Staining: Permanent black/dark brown on treated decay; none on healthy enamel; temporary on soft tissue/skin/clothes
Ask: Which surfaces, how many applications, and is arrest vs aesthetics the goal? ⁵

Fluoride varnish

Active: 5% sodium fluoride (22,600 ppm F)
Other: Rosin, alcohol, propylene glycol, sweeteners
Staining: None permanent on teeth
Ask: Frequency, swallow risk in young children, and non-fluoride options if the family prefers them.

Fluoride risk snapshot (NTP 2024 / JAMA Pediatrics 2025)

Children: Moderate confidence of inverse association with IQ at higher exposure levels.^1,2
Adults: No clear cognitive effects reported.^1,2
Uncertainty remains at the U.S. optimal water level of 0.7 mg/L.⁴ Chairside varnish and SDF are concentrated, time-limited exposures, still worth naming out loud for young children.

Epigenetic Mechanisms

DNA methylation

Persistent and potentially transgenerational. Most relevant long-term concern for both fluoride exposure and certain anesthetic exposures (especially volatiles in developmental or aged windows).^3,8

Histone modifications

Mostly reversible. Shorter-term impact on gene expression.

Non-coding RNA

Usually transient. Less durable than DNA methylation changes.

Deep dive: long-term & persistent aspects of DNA methylation

Why DNA methylation is the longer-term concern. DNA methylation at CpG sites is a relatively stable epigenetic mark. Once established, it can be maintained through cell division by DNA methyltransferases (especially DNMT1). This makes it more durable than histone modifications (often dynamic and reversible) or most non-coding RNAs (usually transient).

Developmental windows. During prenatal life, early childhood, and other periods of high epigenetic plasticity, exposures can more readily set lasting methylation patterns. Fluoride-related studies (Balasubramanian & Perumal 2022 systematic review; Wang et al. 2021 on NNAT and CALCA in school-age children) associate higher fluoride exposure with altered methylation of genes linked to neuronal development and related pathways. These changes are of greater interest when they occur while the brain is still developing.

“Potentially transgenerational.” Some epigenetic marks can, in principle, be passed to offspring without a DNA sequence change. In mammals true transgenerational inheritance (effects in F3, or F2 after pregnancy exposure, after the original exposure has ended) is possible but uncommon and hard to prove. For fluoride the evidence remains limited and preliminary: most data concern the exposed individual or immediate offspring. Reviews note the theoretical possibility; they do not establish robust human transgenerational inheritance of fluoride-related methylation changes.

Mechanistic notes from primary work. Related studies (including TET1 / Bcl2 hydroxymethylation in neural tissue after prenatal fluoride exposure, and promoter hypermethylation examples such as Rad51 in brain) point to pathways that can influence neuronal survival, DNA repair, and function. These remain largely within the directly exposed generation or its immediate offspring.

Page-level takeaway. DNA methylation is highlighted as the most relevant long-term concern in the fluoride exposure data because of this greater persistence. Combined with the NTP 2024 and JAMA Pediatrics 2025 findings on higher fluoride exposure and lower IQ scores in children (moderate confidence at higher doses), the epigenetic literature supplies a plausible biological pathway that could help explain lasting effects from developmental exposures. At typical U.S. community water levels (0.7 mg/L) and for brief, concentrated chairside applications (varnish or SDF), absolute risk remains under evaluation. The emphasis here is awareness and informed choice, especially for young children.

Sources: Balasubramanian S, Perumal E. Crit Rev Toxicol. 2022 (ref 3); Wang et al. DNA methylation and fluoride exposure in school-age children, 2021; NTP 2024; JAMA Pediatrics 2025. These sources do not claim every fluoride-related methylation change is permanent or inherited—only that DNA methylation is the more stable of the epigenetic mechanisms examined.

Genetic Polymorphisms in Dental Care

Key variants frequently discussed around methylation, pain perception, anesthetic response, periodontal risk, and healing. Most dental outcomes remain multifactorial (genetics + environment). Evidence strength varies.

MTHFR

Common variants: C677T (rs1801133), A1298C (rs1801131).

Reduce enzyme activity, raise homocysteine, impair folate/B12 methylation. Discussed for higher periodontal inflammation risk, delayed healing, possible caries susceptibility, midline developmental issues, and nitrous oxide sensitivity.

COMT

Key variants: Val158Met (rs4680), rs4818.

Affects catecholamine metabolism. Lower-activity alleles linked to higher pain sensitivity. Associated with dental pain reports, TMJ/TMD risk, dental anxiety, and variable post-procedure pain or opioid response.

ADRA2A

Alpha-2 adrenergic receptor variants (e.g., C-1291G).

More studied with dexmedetomidine sedation. Potential relevance to epinephrine/vasoconstrictor response in local anesthetics and stress/anxiety amplification; direct dental local-anesthesia data remain limited.

Other Frequently Mentioned Variants

Gene / Cluster	Main Dental Relevance	Notes
IL-1 cluster (IL1A −889, IL1B +3954)	Periodontal disease susceptibility	Classic composite genotype for higher risk of severe/progressive periodontitis; interacts with smoking and bacteria.
OPRM1 (A118G / rs1799971)	Opioid response & pain	Variable efficacy and side effects with post-procedure opioids.
SCN9A / SCN10A	Local anesthetic efficacy	Sodium channel variants linked to differences in block success or resistance in some studies.
MC1R (red-hair related)	Dental anxiety	Associated with higher dental anxiety; mixed data on pure anesthetic efficacy.
Enamel genes (AMELX, ENAM, etc.)	Caries susceptibility	Affect enamel quality/mineralization as part of multifactorial risk.
CYP2D6, CYP2C9	Drug metabolism	Codeine, certain NSAIDs/analgesics, antibiotics — dosing and adverse-effect relevance.

Practical mapping:

Periodontal risk → IL-1 family is the classic candidate.
Pain, anxiety, anesthetic response → COMT, OPRM1, sodium-channel genes, secondarily ADRA/MC1R.
Healing, inflammation, folate pathway → MTHFR appears frequently in functional dentistry discussions.

Precision or pharmacogenetic testing in dentistry remains emerging. Single polymorphisms rarely predict outcomes with high certainty; gene–environment interactions matter most.

Oral Health and Cardiovascular Risk

Consistent association

Periodontal disease is linked to higher risk of heart attack, stroke, atrial fibrillation, heart failure, and other ASCVD outcomes. Relative risks are typically modest (roughly 1.1–1.5) and larger with severe disease or combined oral problems (e.g., periodontitis + caries).¹⁰

Inflammation pathway

Chronic gingival inflammation elevates systemic markers (CRP, IL-6, TNF-α), promotes endothelial dysfunction, and may allow oral pathogens or their products into the circulation. This overlaps with the inflammatory and epigenetic themes elsewhere on this page.

Treatment signals

Intensive periodontal therapy has been shown to slow carotid intima-media thickening and improve endothelial function in a randomized trial. Hard cardiovascular event reduction is not yet proven by large outcome trials.¹¹

Deep dive: current evidence balance

Association is well supported. Multiple observational studies, meta-analyses, and the 2025 American Heart Association scientific statement document an independent link between periodontal disease and atherosclerotic cardiovascular disease after accounting for shared risk factors. Mechanisms include systemic inflammation and possible bacteremia. Mendelian randomization results remain mixed and do not yet establish strong unidirectional causality.¹⁰

Interventional data are improving but incomplete. A 2025 randomized trial (Orlandi et al., European Heart Journal) found that intensive full-mouth periodontal treatment reduced progression of carotid artery wall thickening (~0.02 mm less at 24 months) and improved flow-mediated dilation compared with standard cleaning in otherwise healthy adults. Meta-analyses also show reductions in inflammatory markers and blood pressure with periodontal therapy. Large trials powered for myocardial infarction, stroke, or death as primary endpoints are still needed.¹¹

Practical behaviors matter. Prospective data link regular flossing and routine dental visits to lower stroke risk. Childhood oral disease has been associated with later adult atherosclerosis in registry studies. These findings reinforce oral hygiene as a modifiable factor rather than a guaranteed preventive therapy.

Relevance to methylation and polymorphisms. Sustained periodontal inflammation can influence DNA methylation and other epigenetic marks. IL-1 family variants (already noted in the polymorphisms section) are among the classic genetic candidates for both periodontal severity and inflammatory burden—relevant to the systemic load discussed here.

Bottom line consistent with current reviews (including AHA 2025): treating and preventing periodontal disease is a reasonable, low-risk strategy that reduces chronic inflammation and improves intermediate vascular markers. It should be viewed as complementary to established cardiovascular risk-factor management, not a substitute for it.

Fair clinical takeaway: Maintain excellent oral hygiene, address active periodontitis, and consider the mouth as part of overall inflammatory and cardiovascular risk assessment—particularly in patients who already carry traditional risk factors. Do not claim that dental treatment alone prevents heart attacks or strokes.

What Patients & Families Can Do

Before the visit

Email the chair + agent questions before the slot is booked
Ask which anesthetic, epi/sulfites, nitrous, and fluoride/SDF plan
Optimize food folate, B12, B6, B2, and choline in the days before

During care

Hand the chairside sheet to the assistant before the cartridge is opened
Confirm lowest effective volume and concentration
Note staining expectations if SDF is applied

After care

Support recovery with methyl-donor rich foods
Track unusual reactions (rash, palpitations, lingering numbness)
Write the exact agent used on the sheet for the next office

Say this at the chair

“I need dentistry done well. I also track methylation. Please tell me the anesthetic, percent, epi ratio, and whether the cartridge has sulfites, and confirm whether fluoride, SDF, or nitrous is planned before you start.”

Short, specific, not confrontational. The chairside sheet below carries the same ask on paper.

Chair sheet & email questions

Two panels. Left: fold and take to the dentist. Right: copy into an email before the appointment is set. Print portrait (one panel per page) or landscape (both on one page).

Bring to the chair

Methyl Dental chairside sheet

Hand this to the dentist or assistant before the cartridge is opened. This is a preference sheet, not a refusal of care.

Patient / child: _______________________________
Date / office: _______________________________
Please name the anesthetic (agent, %, epi ratio) before injection.
Sulfites: I prefer a plain (no-epinephrine) cartridge if clinically reasonable.
Volume: Lowest effective volume and concentration.
Nitrous oxide: Please confirm if it will be used. I prefer to skip it when possible.
Fluoride / SDF: Please confirm the product and surfaces before application. Note SDF staining.
Sensitivities on file: sulfites / prior anesthetic reaction / low B12 / child IQ-exposure concern (circle).

What was actually used (fill after): agent ______ % ______ epi ______ mL ______ nitrous Y/N fluoride/SDF ______

Email before you book

Questions for the dental team

Paste into a message to the office before the appointment is set. Ask them to reply in writing.

Subject: Agent and fluoride questions before scheduling: [name]

1. Which local anesthetic do you typically use for this procedure (agent, percent, epinephrine ratio)?
2. Do you stock a plain (no-epinephrine / no-sulfite) cartridge if we prefer it?
3. Will nitrous oxide be offered or expected? Is there an alternative?
4. Is fluoride varnish or silver diamine fluoride planned? Which product, and on which surfaces?
5. For SDF: can you confirm we understand permanent staining on decayed surfaces?
6. Who on the team can note these preferences in the chart before we arrive?
7. If the plan changes on the day, can the treating dentist review the chairside sheet with us first?

Closing line you can use: “We want the dentistry done. We are asking so the visit is planned, not negotiated in the chair.”

FAQ

Do I have to refuse fluoride to protect methylation?

No. The ask is named exposure, not a ban. Varnish and SDF are concentrated and time-limited. For young children, frequency, swallow risk, and whether arrest of decay is the real goal are the useful questions.^1,2,4,5

Is a “plain” cartridge always safer?

Plain means no epinephrine and usually no metabisulfite. Duration of numbness is shorter and bleeding control is weaker. It is a preference for sulfite-sensitive patients, not a universal upgrade. The dentist still owns the clinical call.

Should every child skip nitrous?

No. Short, infrequent N₂O is not the same as prolonged surgical exposure. It is still reasonable to ask, especially with low B12, vegetarian diet, or repeated visits.⁷

Why email before booking instead of asking at check-in?

Cartridge stock and fluoride protocols are office-level decisions. If the only option is a sulfite-preserved articaine-with-epi and you wanted plain lidocaine, that is easier to solve a week out than at 2:05 in the chair.

For Dental Providers

Agent selection

Prefer lower-toxicity agents when clinically appropriate. Document preservatives and vasoconstrictor concentrations. Stock at least one plain cartridge.⁶

Fluoride counseling

Discuss risk → benefit of SDF vs varnish, especially in young children. Name permanent staining with SDF before the brush comes out.⁵

Record keeping

Log anesthetic type, concentration, epi ratio, lot #, volume, site, nitrous Y/N, and patient response. That log is the next visit’s starting point.

References

Selected sources on fluoride neurodevelopment, dental anesthetics, SDF, and nitrous / B12. Dates reflect the source as cited; always re-check the live record.

1. NTP Monograph on Fluoride Neurodevelopment, 2024.

2. JAMA Pediatrics meta-analysis on fluoride and IQ, 2025.

3. Fluoride-associated DNA methylation and epigenetic changes in neural cells (systematic reviews).

4. U.S. PHS / CDC / ADA statements on 0.7 mg/L; WHO guideline 1.5 mg/L.

5. SDF clinical literature → AAPD guidelines and caries-arrest reviews.

6. Dental local anesthetic pharmacology and toxicity reviews.

7. Nitrous oxide and methionine synthase / B12 oxidation → classic hematology and anesthesia literature.

1. National Toxicology Program. NTP monograph on the state of the science concerning fluoride exposure and neurodevelopment and cognition. 2024. NTP

2. Taylor KW, et al. Fluoride exposure and children’s IQ scores: a systematic review and meta-analysis. JAMA Pediatrics. 2025. JAMA Pediatrics

3. Reviews on fluoride-associated DNA methylation and other epigenetic changes in neural cells. Balasubramanian S, Perumal E. A systematic review on fluoride-induced epigenetic toxicity in mammals. Crit Rev Toxicol. 2022;52(6):449-468. PubMed · Taylor & Francis · see also Wang et al. on DNA methylation (NNAT, CALCA) in school-age children: Wang 2021

4. U.S. Public Health Service recommendation (2015) of 0.7 mg/L as the optimal concentration for community water systems that add fluoride, endorsed by CDC and ADA; WHO guideline value of 1.5 mg/L (with note that artificial fluoridation is typically 0.5–1.0 mg/L). CDC · ADA · PHS 2015 · WHO guidelines

5. American Academy of Pediatric Dentistry. Policy and clinical guidelines on silver diamine fluoride; systematic reviews on caries arrest. AAPD

6. Standard dental local-anesthetic pharmacology and systemic / CNS toxicity reviews (lidocaine baseline; bupivacaine and etidocaine higher cardiac/CNS risk; sulfite preservatives in most epinephrine-containing cartridges).

7. Nitrous oxide oxidizes cob(I)alamin and can inhibit methionine synthase → classic hematology and anesthesia literature on B12 inactivation.

8. Anesthetic-induced epigenetic alterations: mechanisms and long-term clinical implications. Epigenetics 2025 (review covering DNA methylation, histone marks, intergenerational germline effects from sevoflurane/isoflurane). Supporting primary work: Cabrera et al. / Jevtovic-Todorovic neonatal epigenome reviews; Ju, Wu, Fan et al. on DNMT upregulation and BDNF/Reelin/Arc hypermethylation; intergenerational Kcc2 sperm methylation studies.

9. Human pilot data on intraoperative global DNA hypomethylation under opioid-based general anesthesia (e.g., fentanyl for major breast surgery) with partial recovery by ~48 h; in-vitro demethylating effects of lidocaine/ropivacaine. Local-anesthetic long-term locus-specific brain data remain limited compared with volatile models.

10. Tran AH, et al. Periodontal Disease and Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation. 2025 (published online Dec 16, 2025). Updated statement confirming independent association, mechanisms (bacteremia, chronic inflammation), and call for further outcome trials. DOI: 10.1161/CIR.0000000000001390.

11. Orlandi M, et al. Periodontitis treatment and progression of carotid intima-media thickness: a randomized trial. European Heart Journal. 2025;ehaf555. Intensive periodontal treatment slowed cIMT progression (~0.02 mm less at 24 months) and improved endothelial function vs standard care in otherwise healthy adults with periodontitis.